Pre‐treatment of synthetic elastomeric scaffolds by cardiac fibroblasts improves engineered heart tissue
- 27 November 2007
- journal article
- research article
- Published by Wiley in Journal of Biomedical Materials Research Part A
- Vol. 86A (3), 713-724
- https://doi.org/10.1002/jbm.a.31578
Abstract
Native myocardium consists of several cell types, of which approximately one-third are myocytes and most of the nonmyocytes are fibroblasts. By analogy with monolayer culture in which fibroblasts were removed to prevent overgrowth, early attempts to engineer myocardium utilized cell populations enriched for cardiac myocytes (CMs; ∼80–90% of total cells). We hypothesized that the pre-treatment of synthetic elastomeric scaffolds with cardiac fibroblasts (CFs) will enhance the functional assembly of the engineered cardiac constructs by creating an environment supportive of cardiomyocyte attachment and function. Cells isolated from neonatal rat ventricles were prepared to form three distinct populations: rapidly plating cells identified as CFs, slowly plating cells identified as CMs, and unseparated initial population of cells (US). The cell fractions (3 × 106 cells total) were seeded into poly(glycerol sebacate) scaffolds (highly porous discs, 5 mm in diameter × 2-mm thick) using Matrigel™, either separately (CM or CF), concurrently (US), or sequentially (CF pre-treatment followed by CM culture, CF + CM), and cultured in spinner flasks. The CF + CM group had the highest amplitude of contraction and the lowest excitation threshold, superior DNA content, and higher glucose consumption rate. The CF + CM group exhibited compact 100- to 200-μm thick layers of elongated myocytes aligned in parallel over layers of collagen-producing fibroblasts, while US and CM groups exhibited scattered and poorly elongated myocytes. The sequential co-culture of CF and CM on a synthetic elastomer scaffold thus created an environment supportive of cardiomyocyte attachment, differentiation, and contractile function, presumably due to scaffold conditioning by cultured fibroblasts. When implanted over the infarcted myocardium in a nude rat model, cell-free poly(glycerol sebacate) remained at the ventricular wall after 2 weeks of in vivo, and was vascularized. © 2007 Wiley Periodicals, Inc. J Biomed Mater Res 2008Keywords
This publication has 33 references indexed in Scilit:
- Biomimetic Approach to Cardiac Tissue Engineering: Oxygen Carriers and Channeled ScaffoldsTissue Engineering, 2006
- Inhibition of fibroblast proliferation in cardiac myocyte cultures by surface microtopographyAmerican Journal of Physiology-Cell Physiology, 2003
- High‐density seeding of myocyte cells for cardiac tissue engineeringBiotechnology & Bioengineering, 2003
- Dance Band on the TitanicCirculation Research, 2002
- Mechanical Stretch Regimen Enhances the Formation of Bioengineered Autologous Cardiac Muscle GraftsCirculation, 2002
- A tough biodegradable elastomerNature Biotechnology, 2002
- Cardiac Fibrosis as a Cause of Diastolic DysfunctionHerz, 2002
- Tissue Engineering of a Differentiated Cardiac Muscle ConstructCirculation Research, 2002
- Tissue engineering of functional cardiac muscle: molecular, structural, and electrophysiological studiesAmerican Journal of Physiology-Heart and Circulatory Physiology, 2001
- Chronic stretch of engineered heart tissue induces hypertrophy and functional improvementThe FASEB Journal, 2000